Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response (2008)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidades: FCF; HU
- Subjects: HIPERCOLESTEROLEMIA; EXPRESSÃO GÊNICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical Chemistry and Laboratory Medicine
- ISSN: 1434-6621
- Volume/Número/Paginação/Ano: v. 46 , n. 8, p. A138, 2008
- Conference titles: Biologie Prospective Santorini Conference
-
ABNT
RODRIGUES, Alice Cristina et al. Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 abr. 2024. , 2008 -
APA
Rodrigues, A. C., Genvigir, F. D. V., Arazi, S. S., Willrich, M. A. V., Hirata, M. H., Hirata, R. D. C., et al. (2008). Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response. Clinical Chemistry and Laboratory Medicine. Berlin: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Rodrigues AC, Genvigir FDV, Arazi SS, Willrich MAV, Hirata MH, Hirata RDC, Dórea EL, Bernik MMS. Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( 8): A138.[citado 2024 abr. 16 ] -
Vancouver
Rodrigues AC, Genvigir FDV, Arazi SS, Willrich MAV, Hirata MH, Hirata RDC, Dórea EL, Bernik MMS. Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response. Clinical Chemistry and Laboratory Medicine. 2008 ; 46 ( 8): A138.[citado 2024 abr. 16 ] - CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin down-regulates ABCA1 gene expression in peripheral blood mononuclear cells of Brazilian hyper-cholesterolemic patients
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
- Efeitos de polimorfismo genético do SREBF1 sobre o perfil lipídico sérico de indivíduos sob terapia hipolipemiante
- Efeito da atorvastatina sobre os genes SREBF1, SREBF2 e SCAP em pacientes hipercolesterolêmicos
- Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy
- Resposta hipolipemiante à atorvastatina é modificada pelo polimorfismo do gene da CYP3A5
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
